European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Safety of secondary CRS/HIPEC in peritoneal surface malignancies: Insights from a national cohort study.
Lukas Pollmann, Jürgen Zieren, Nicola S Pollmann, Urs Giger-Pabst, Pompiliu Piso, Michael Ströhlein, Nicola Cerasani, Fabian Kockelmann, Maximilian Schmeding, members of the StuDoQ|HIPEC registry of the German Society for General and Visceral Surgery (DGAV)
Published: 202610.1016/j.ejso.2026.111408
Abstract
BACKGROUND: For carefully selected patients with peritoneal surface malignancies (PSMs), secondary cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) can provide similar oncological results as primary CRS/HIPE…
Preview only. Read the full abstract at the source